Tumour growth rates in squamous carcinoma of the head and neck measured by in vivo bromodeoxyuridine incorporation and flow cytometry
1992

Tumour Growth Rates in Squamous Carcinoma of the Head and Neck

Sample size: 82 publication Evidence: moderate

Author Information

Author(s): G. Forster, T.G. Cooke, L.D. Cooke, P.D. Stanton, G. Bowie, P.M. Stell

Primary Institution: University Departments of Surgery and Otorhinolaryngology, Glasgow Royal Infirmary

Hypothesis

Do cell kinetic parameters, particularly potential doubling time, have predictive value regarding prognosis and response to treatment in squamous cell carcinomas of the head and neck?

Conclusion

The study found that aneuploid tumours had a higher labelling index and shorter potential doubling time compared to diploid tumours.

Supporting Evidence

  • Aneuploid tumours had a significantly higher BrdUrd labelling index and shorter potential doubling time than diploid tumours.
  • The median labelling index for all tumours was 8.0%, with aneuploid tumours showing a median of 9.5%.
  • The potential doubling times for aneuploid tumours were significantly shorter than for diploid tumours.

Takeaway

This study looked at how fast certain types of cancer grow and found that some cancers grow faster than others, which can help doctors decide how to treat them.

Methodology

The study involved administering bromodeoxyuridine to patients and measuring various cell kinetic parameters using flow cytometry on tissue samples.

Limitations

Some samples did not have enough tumour tissue for analysis, and there were issues with BrdUrd staining profiles in a few cases.

Participant Demographics

Patients with previously untreated and recurrent squamous cell tumours of the head and neck.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication